Using microfluidics platform to measure toxicology biomarkers with less sample
Do more with less. It’s an age-old concept, but this mantra especially resonates in today’s pre-clinical toxicology world as the pharmaceutical industry faces greater than ever challenges in getting lead compounds to market.
